SCHEMBL30185823

SCHEMBL30185823

Cn1ccc(N)c(-c2cccnc2)c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 4/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ CYP2A13 Q16696 1/20 0.47
▸ GRM2 Q14416 2/20 0.42
▸ AURKA O14965 1/20 0.42
▸ TTK P33981 1/20 0.42
▸ AURKB Q96GD4 1/20 0.42
▸ INCENP Q9NQS7 1/20 0.42
▸ CYP2E1 P05181 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2B6 P20813 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ DHPS P49366 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ HSP90AB1 P08238 1/20 0.40
▸ PTK2 Q05397 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ TLR8 Q9NR97 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15717101 0.80 ALDH1A1 (0.46) ALDH1A1MEN1
SCHEMBL6691335 0.76 CYP2A6 (0.58) CYP2A6ALDH1A1AURKATTKAURKB
SCHEMBL30445600 0.74 CYP2A6 (0.49) CYP2A6ALDH1A1CYP2A13GRM2CYP2E1
SCHEMBL6172101 0.74 CYP2A6 (0.53) CYP2A6ALDH1A1CYP2E1CYP2C9CYP2B6
SCHEMBL30577111 0.73 CYP2A6 (0.60) CYP2A6ALDH1A1CYP2A13GRM2CYP2E1
SCHEMBL30522560 0.71 BACE1 (0.46) CYP2A6AURKATTKAURKBINCENP
SCHEMBL30522588 0.71 KCNA3 (0.45) CYP2A6ALDH1A1CYP2A13CYP2E1CYP2C9
SCHEMBL30109018 0.70 CYP2A6 (0.53) CYP2A6ALDH1A1CYP2A13GRM2CYP2E1
SCHEMBL4053682 0.70 CYP2A6 (0.49) CYP2A6AURKATTKAURKBINCENP
SCHEMBL31743133 0.70 GRM2 (0.71) GRM2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115702145-A Substituted pyridines for the treatment of inflammatory diseases 戈萨默生物服务公司 2023-02-14 — — CN disclosed
Send feedback